Compare FLEX & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLEX | ZBH |
|---|---|---|
| Founded | 1990 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3B | 19.5B |
| IPO Year | 1997 | 2001 |
| Metric | FLEX | ZBH |
|---|---|---|
| Price | $67.88 | $91.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 19 |
| Target Price | $61.11 | ★ $104.76 |
| AVG Volume (30 Days) | ★ 2.8M | 1.9M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.66 | ★ 3.55 |
| Revenue | ★ $28,679,925,000.00 | $8,231,500,000.00 |
| Revenue This Year | $8.11 | $4.93 |
| Revenue Next Year | $6.28 | $3.72 |
| P/E Ratio | $40.72 | ★ $25.63 |
| Revenue Growth | ★ 18.95 | 7.20 |
| 52 Week Low | $27.45 | $84.59 |
| 52 Week High | $72.22 | $108.29 |
| Indicator | FLEX | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 51.35 |
| Support Level | $57.27 | $89.16 |
| Resistance Level | $71.48 | $95.33 |
| Average True Range (ATR) | 3.42 | 1.91 |
| MACD | 0.34 | 0.37 |
| Stochastic Oscillator | 73.65 | 93.91 |
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.